Australian Statistics on Medicines 2010
Table 1 - Blood And Blood Forming Organs
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B01AA02 |
PHENINDIONE |
||||||
A |
14975 |
Tablet 10mg |
0.10 |
GM |
210 |
— |
|
B01AA03 |
WARFARIN |
||||||
P |
2209G |
Tablet 2mg |
7.50 |
MG |
1,014,872 |
12,929,453 |
|
P |
2211J |
Tablet 5mg |
7.50 |
MG |
729,341 |
10,183,677 |
|
P |
2843P |
Tablet 1mg |
7.50 |
MG |
1,151,442 |
14,285,027 |
|
P |
2844Q |
Tablet 3mg |
7.50 |
MG |
334,909 |
4,217,296 |
|
HEPARIN GROUP |
|||||||
B01AB04 |
DALTEPARIN |
||||||
P |
2816F |
Inj 5,000 units (anti-Xa) in 0.2mL syringe |
2.50 |
TE |
7,387 |
478,898 |
|
P |
8269F |
Inj 10,000 units (anti-Xa) in 1mL syringe |
2.50 |
TE |
299 |
67,506 |
|
P |
8271H |
Inj 7,500 units (anti-Xa) in 0.75mL syringe |
2.50 |
TE |
316 |
59,698 |
|
P |
8603T |
Inj 2,500 units (anti-Xa) in 0.2mL syringe |
2.50 |
TE |
4,312 |
236,142 |
|
P |
8641T |
Inj 2,500 units (anti-Xa) in 0.2mL syringe |
2.50 |
TE |
1,400 |
116,845 |
|
P |
8642W |
Inj 5,000 units (anti-Xa) in 0.2mL syringe |
2.50 |
TE |
2,356 |
217,737 |
|
P |
8643X |
Inj 7,500 units (anti-Xa) in 0.75mL syringe |
2.50 |
TE |
234 |
35,135 |
|
B01AB05 |
ENOXAPARIN |
||||||
P |
8262W |
Inj 60mg (6000u anti-Xa) in 0.6mL syringe |
2.00 |
TE |
30,975 |
3,808,573 |
|
P |
8263X |
Inj 80mg (8000u anti-Xa) in 0.8mL syringe |
2.00 |
TE |
55,942 |
7,676,524 |
|
P |
8264Y |
Inj 100mg (10000u anti-Xa) in 1 mL syringe |
2.00 |
TE |
58,581 |
10,009,771 |
|
P |
8510X |
Inj 40mg (4000u anti-Xa) in 0.4 mL syringe 20 |
2.00 |
TE |
93,283 |
7,762,956 |
|
P |
8558K |
Inj 20mg (2000u anti-Xa) in 0.2mL syringe 20 |
2.00 |
TE |
36,519 |
2,707,764 |
|
P |
8639Q |
Inj 40mg (4000u anti-Xa) in 0.4mL syringe |
2.00 |
TE |
26,170 |
2,458,013 |
|
P |
8640R |
Inj 60mg (6000u anti-Xa) in 0.6mL syringe |
2.00 |
TE |
14,670 |
2,002,173 |
|
P |
8716R |
Inj 20mg (2000u anti-Xa) in 0.2mL syringe |
2.00 |
TE |
8,978 |
779,118 |
|
P |
9195Y |
Solution for injection 40mg (4000 i.u. anti-Xa) 20 |
2.00 |
TE |
17,133 |
1,597,923 |
|
P |
9196B |
Solution for injection 40mg (4000 i.u. anti-Xa) 20 |
2.00 |
TE |
7,062 |
689,104 |
|
B01AB01 |
HEPARIN SODIUM |
||||||
P |
1076P |
Injection 35,000 units in 35mL 12 |
10.00 |
TE |
1,231 |
299,804 |
|
P |
1463B |
Injection 5,000 units in 5mL |
10.00 |
TE |
6,877 |
386,921 |
|
P |
1466E |
Injection 5,000 units in 0.2mL |
10.00 |
TE |
41,617 |
670,598 |
|
PLATELET AGGREGATION INHIBITORS EXCL. HEPARIN |
|||||||
B01AC13 |
ABCIXIMAB |
||||||
P |
8048N |
I.V.injection 10mg in 5mL |
25.00 |
MG |
1,340 |
1,916,291 |
|
B01AC06 |
ASPIRIN |
||||||
A |
10544 |
Tablet 100mg 30 |
0.10 |
GM |
929 |
— |
|
A |
10599 |
Tablet 100mg 28 |
0.10 |
GM |
11,866 |
— |
|
A |
13020 |
Capsule 100mg 28 |
0.10 |
GM |
441 |
— |
|
P |
4076M |
Tablet 100mg (enteric coated) |
0.10 |
GM |
15,509 |
242,642 |
|
P |
4077N |
Tablet 100mg (enteric coated) |
0.10 |
GM |
95,384 |
1,305,745 |
|
P |
4078P |
Capsule 100mg (enteric coated pellets) |
0.10 |
GM |
11,990 |
175,113 |
|
P |
8202Q |
Tablet 100mg |
0.10 |
GM |
1,152,769 |
9,283,630 |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B01AC04 |
CLOPIDOGREL |
||||||
P |
4179Y |
Tablet 75mg (as hydrogen sulfate) 28 |
75.00 |
MG |
3,648 |
279,087 |
|
P |
8358X |
Tablet 75mg (as hydrogen sulfate) 28 |
75.00 |
MG |
2,598,635 |
192,504,935 |
|
P |
9317J |
Tablet 75mg (as hydrogen sulfate) 28 |
75.00 |
MG |
225,827 |
16,129,357 |
|
P |
9354H |
Tablet 75mg (as hydrogen sulfate) 28 |
75.00 |
MG |
90,571 |
6,481,982 |
|
B01AC30 |
CLOPIDOGREL with ASPIRIN |
||||||
P |
9296G |
Tablet 75mg (as hydrogen sulfate)-100mg 30 |
— |
— |
252,126 |
19,394,889 |
|
B01AC07 |
DIPYRIDAMOLE |
||||||
A |
13040 |
Tablet 100mg 100 |
0.40 |
GM |
1,094 |
— |
|
P |
8335Q |
Capsule 200mg (sustained release) |
0.40 |
GM |
42,134 |
1,554,131 |
|
B01AC30 |
DIPYRIDAMOLE with ASPRIN |
||||||
P |
8382E |
Capsule 200mg (sustained release)-25mg |
— |
— |
509,424 |
18,907,641 |
|
B01AC09 |
EPOPROSTENOL |
||||||
P |
6478Y |
Powder for I.V. infusion 1.5mg with diluent |
— |
— |
235 |
1,019,343 |
|
B01AC16 |
EPTIFIBATIDE |
||||||
P |
8683B |
Solution for I.V. injection 20mg (base) in 10mL |
0.20 |
GM |
638 |
159,836 |
|
P |
8684C |
Solution for I.V. infusion 75mg (base) in 100mL |
0.20 |
GM |
512 |
444,743 |
|
B01AC11 |
ILOPROST |
||||||
P |
6456T |
Solution for inhalation 20ug (base) in 2mL 30 |
0.15 |
MG |
240 |
1,772,268 |
|
B01AC22 |
PRASUGREL |
||||||
P |
9495R |
Tablet 5mg (as hydrochloride) 28 |
10.00 |
MG |
663 |
63,889 |
|
P |
9496T |
Tablet 10mg (as hydrochloride) 28 |
10.00 |
MG |
9,746 |
1,032,893 |
|
B01AC05 |
TICLOPIDINE HYDROCHLORIDE |
||||||
P |
2095G |
Tablet 250mg |
0.50 |
GM |
1,034 |
147,551 |
|
B01AC17 |
TIROFIBAN |
||||||
P |
8350L |
Solution concentrate I.V. infusion 12.5mg in 50mL |
10.00 |
MG |
1,463 |
565,420 |
|
ENZYMES |
|||||||
B01AD11 |
TENECTEPLASE |
||||||
P |
8527T |
Powder for injection 50mg with solvent |
40.00 |
MG |
170 |
353,040 |
|
DIRECT THROMBIN INHIBITORS |
|||||||
B01AE06 |
BIVALIRUDIN |
||||||
P |
8844L |
Powder for I.V. injection 250mg (base) |
0.25 |
GM |
2,637 |
1,861,833 |
|
OTHER ANTITHROMBOTIC AGENTS |
|||||||
B01AX06 |
RIVAROXABAN |
||||||
P |
9465E |
Tablet 10mg 10 |
10.00 |
MG |
731 |
164,588 |
|
P |
9466F |
Tablet 10mg 15 |
10.00 |
MG |
1,847 |
356,847 |
|
P |
9467G |
Tablet 10mg 30 |
10.00 |
MG |
2,835 |
818,859 |
|
P |
9468H |
Tablet 10mg 10 |
10.00 |
MG |
722 |
89,177 |
|
P |
9469J |
Tablet 10mg 15 |
10.00 |
MG |
4,957 |
712,328 |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B02AA02 |
TRANEXAMIC ACID |
||||||
P |
2180R |
Tablet 500mg |
2.00 |
GM |
42,136 |
2,161,714 |
|
VITAMIN K AND OTHER HAEMOSTATICS |
|||||||
VITAMIN K |
|||||||
B02BA01 |
PHYTOMENADIONE |
||||||
A |
11080 |
Tablet 10mg 100 |
20.00 |
MG |
207 |
— |
|
A |
16049 |
Ampoule 10mg/mL 5 |
20.00 |
MG |
467 |
— |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B03AA07 |
FERROUS SULPHATE |
||||||
A |
16996 |
Tablet |
0.20 |
GM |
64,078 |
— |
|
P |
8815Y |
Oral liquid 30mg per mL, 250mL |
0.20 |
GM |
43,362 |
854,057 |
|
IRON TRIVALENT, PARENTERAL PREPARATIONS |
|||||||
B03AC03 |
IRON POLYMALTOSE COMPLEX |
||||||
P |
2593L |
Injection 100mg (iron) in 2mL |
0.10 |
GM |
53,033 |
2,974,128 |
|
B03AC02 |
SACCHARATED IRON OXIDE |
||||||
P |
8807M |
Concent for soln for infus 2.7g =100mg iron in 5mL |
0.10 |
GM |
382 |
51,395 |
|
IRON IN COMBINATION WITH FOLIC ACID |
|||||||
B03AD02 |
FERROUS FUMARATE with FOLIC ACID |
||||||
P |
9011G |
Tablet 310mg-350ug |
— |
— |
231,999 |
2,955,552 |
|
B03AD03 |
FERROUS SULPHATE DRIED with FOLIC ACID |
||||||
A |
14528 |
Capsule 270mg-300ug (delayed release) |
— |
— |
5,765 |
— |
|
A |
18904 |
Tablet 270mg-300ug (sustained release) |
— |
— |
28,357 |
— |
|
VITAMIN B12 AND FOLIC ACID |
|||||||
VITAMIN B12 (CYANOCOBALAMIN AND DERIVATIVES) |
|||||||
B03BA03 |
HYDROXOCOBALAMIN |
||||||
P |
9048F |
Injection 1mg in 1mL 3 |
20.00 |
UG |
337,288 |
5,769,798 |
|
FOLIC ACID AND DERIVATIVES |
|||||||
B03BB01 |
FOLIC ACID |
||||||
P |
1437P |
Tablet 5mg |
— |
— |
127,520 |
1,731,494 |
|
P |
2958Q |
Tablet 500ug |
0.40 |
MG |
49,065 |
657,451 |
|
OTHER ANTIANAEMIC PREPARATIONS |
|||||||
OTHER ANTIANAEMIC PREPARATIONS |
|||||||
B03XA02 |
DARBEPOETIN ALPHA |
||||||
P |
6320P |
Injection 10ug in 0.4mL syringe 8 |
4.50 |
UG |
308 |
64,456 |
|
P |
6321Q |
Injection 20ug in 0.5mL syringe 8 |
4.50 |
UG |
2,600 |
1,016,778 |
|
P |
6322R |
Injection 30ug in 0.3mL syringe 8 |
4.50 |
UG |
3,213 |
1,738,690 |
|
P |
6323T |
Injection 40ug in 0.4mL syringe 8 |
4.50 |
UG |
8,850 |
5,976,727 |
|
P |
6324W |
Injection 50ug in 0.5mL syringe 8 |
4.50 |
UG |
1,272 |
1,065,133 |
|
P |
6325X |
Injection 60ug in 0.3mL syringe 8 |
4.50 |
UG |
3,825 |
3,894,496 |
|
P |
6326Y |
Injection 100ug in 0.5mL syringe 8 |
4.50 |
UG |
2,190 |
3,821,366 |
|
P |
6365B |
Injection 150ug in 0.3mL syringe 8 |
4.50 |
UG |
1,101 |
2,592,028 |
|
P |
6438W |
Injection 80ug in 0.4mL syringe 8 |
4.50 |
UG |
1,824 |
2,364,515 |
|
P |
6488L |
Injection 20ug in 0.5mL prefilled injection pen 8 |
4.50 |
UG |
449 |
164,293 |
|
P |
6489M |
Injection 40ug in 0.4mL prefilled injection pen 8 |
4.50 |
UG |
1,544 |
968,900 |
|
P |
6490N |
Injection 60ug in 0.3mL prefilled injection pen 8 |
4.50 |
UG |
481 |
460,959 |
|
P |
6491P |
Injection 80ug in 0.4mL prefilled injection pen 8 |
4.50 |
UG |
279 |
325,548 |
|
P |
6492Q |
Injection 100ug in 0.5mL prefilled injection pen 8 |
4.50 |
UG |
300 |
418,885 |
|
P |
6493R |
Injection 150ug in 0.3mL prefilled injection pen 8 |
4.50 |
UG |
182 |
412,791 |
|
B03XA01 |
EPOETIN ALPHA |
||||||
P |
6205N |
Injection 3,000 units in 0.3mL syringe 12 |
1.00 |
TE |
134 |
75,870 |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
P |
6206P |
Injection 4,000 units in 0.4mL syringe 12 |
1.00 |
TE |
651 |
372,733 |
|
P |
6207Q |
Injection 10,000 units in 1mL syringe 12 |
1.00 |
TE |
936 |
1,430,484 |
|
P |
6302Q |
Injection 5,000 units in 0.5mL syringe 12 |
1.00 |
TE |
111 |
94,241 |
|
P |
6303R |
Injection 6,000 units in 0.6mL syringe 12 |
1.00 |
TE |
822 |
653,760 |
|
P |
6305W |
Injection 8,000 units in 0.8mL syringe 12 |
1.00 |
TE |
747 |
923,307 |
|
P |
6339P |
Injection 40,000 units in 1mL syringe 2 |
1.00 |
TE |
166 |
424,396 |
|
B03XA01 |
EPOETIN BETA |
||||||
P |
6480C |
Injection 2,000 units in 0.3mL syringe 12 |
1.00 |
TE |
126 |
37,202 |
|
P |
6481D |
Injection 3,000 units in 0.3mL syringe 12 |
1.00 |
TE |
235 |
103,046 |
|
P |
6482E |
Injection 4,000 units in 0.3mL syringe 12 |
1.00 |
TE |
1,158 |
678,997 |
|
P |
6483F |
Injection 5,000 units in 0.3mL syringe 12 |
1.00 |
TE |
210 |
150,035 |
|
P |
6484G |
Injection 6,000 units in 0.3mL syringe 12 |
1.00 |
TE |
1,202 |
1,017,634 |
|
P |
6485H |
Injection 10,000 units in 0.6mL syringe 12 |
1.00 |
TE |
1,605 |
2,309,724 |
|
P |
6486J |
Injection 20,000 units in 0.6mL syringe 12 |
1.00 |
TE |
202 |
584,070 |
|
B03XA03 |
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA |
||||||
P |
9575Y |
Injection 50ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
110 |
77,596 |
|
P |
9577C |
Injection 100ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
118 |
139,574 |
|
P |
9578D |
Injection 120ug in 0.3mL prefilled syringe 1 |
4.00 |
UG |
186 |
227,493 |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B05AA06 |
GELATIN SUCCINYLATED |
||||||
P |
8444K |
I.V. infusion 20g per 500mL,500mL |
— |
— |
2,129 |
81,351 |
|
B05AA07 |
HYDROXYETHYLSTARCH |
||||||
P |
9487H |
I.V. infusion 30g per 500mL, 500mL 3 |
— |
— |
567 |
22,454 |
|
I.V. SOLUTIONS |
|||||||
SOLUTIONS FOR PARENTERAL NUTRITION |
|||||||
B05BA03 |
GLUCOSE |
||||||
P |
2245E |
I.V. infusion 278mmol per l (5%) 1L |
— |
— |
720 |
13,681 |
|
SOLUTIONS AFFECTING THE ELECTROLYTE BALANCE |
|||||||
B05BB01 |
SODIUM CHLORIDE |
||||||
P |
2260Y |
I.V. infusion 513mmol per l (3%) 1L |
— |
— |
141 |
2,006 |
|
P |
2264E |
I.V. infusion 154mmol per l (0.9% ) 1L |
— |
— |
23,611 |
690,196 |
|
P |
9392H |
I.V. infusion 77mmol per 500mL (0.9%), 500mL 5 |
— |
— |
1,459 |
17,078 |
|
P |
9473N |
I.V. infusion 38.5mmol per 250mL (0.9%) 250mL 5 |
— |
— |
288 |
6,592 |
|
B05BB01 |
SODIUM CHLORIDE COMPOUND |
||||||
P |
2266G |
I.V. infusion 1L |
— |
— |
295 |
9,204 |
|
B05BB02 |
SODIUM CHLORIDE with GLUCOSE |
||||||
P |
2281C |
I.V. infusion 31mmol-222mmol per l (0.18%-4%) 1L |
— |
— |
4,747 |
110,009 |
|
B05BB01 |
SODIUM LACTATE COMPOUND |
||||||
P |
2286H |
I.V. infusion 1L |
— |
— |
13,196 |
286,052 |
|
IRRIGATING SOLUTIONS |
|||||||
SALT SOLUTIONS |
|||||||
B05CB01 |
SODIUM CHLORIDE |
||||||
P |
4460R |
Irrigation solution 9mg per mL (0 .9%) 500mL |
— |
— |
380 |
4,861 |
|
P |
4461T |
Irrigation solution 9mg per mL (0 .9%) 1L |
— |
— |
253 |
2,748 |
2010 | |||||||
---|---|---|---|---|---|---|---|
ATC | ITEM TYPE | CODE | FORM AND STRENGTH | DDD | UNITS | SCRIPTS | COST($) |
BLOOD AND BLOOD FORMING ORGANS |
|||||||
B06AA03 |
HYALURONIDASE |
||||||
A |
10985 |
Ampoule 1500u 5 |
— |
— |
110 |
— |